PD
PDSB icon

Point72 (DIFC)’s PDS Biotechnology PDSB Stock Holding History

Point72 (DIFC)’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-50
Closed -$66 – 1705
2025
Q2 		$66 Buy
+50
New +$68 ﹤0.01% 1490
2024
Q4 		– Sell
-50
Closed -$191 – 1804
2024
Q3 		$191 Sell
50
-5,030
-99% -$16.8K ﹤0.01% 1361
2024
Q2 		$14.9K Buy
+5,080
New +$16.3K ﹤0.01% 1279

Other funds holding PDSB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 (DIFC)'s PDSB Position: Q3 2025 in Review

Point72 (DIFC) sold out of PDS Biotechnology (PDSB) in Q3 2025, closing a stake of 50 shares — an estimated $66 sold.

Point72 (DIFC) first reported a position in PDSB in Q2 2024 and held it in 3 quarters. The position peaked at $14.9K in Q2 2024. 47 funds tracked by Wall St. Rank hold PDSB as of Q3 2025.

  • Point72 (DIFC) reported no remaining PDS Biotechnology position as of Q3 2025 after selling out during the quarter.
  • Point72 (DIFC) sold 50 PDS Biotechnology shares in Q3 2025, an estimated $66.
  • Point72 (DIFC) first reported a position in PDS Biotechnology in Q2 2024 and held it in 3 quarters.
  • Point72 (DIFC)'s PDS Biotechnology position peaked at $14.9K in Q2 2024.
  • 47 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.